Federal regulators approved new suppliers for two crucial cancer drugs. An oncologist at the NYU Cancer Institute says the move could ease shortages and fears that patients, particularly children with leukemia, would miss lifesaving treatments. (Feb. 21)
Posted by Breaking News Online
on February 21, 2012. Filed under News, Video.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.